Dr. Jhaveri Discusses the Potential of Immunotherapy in TNBC
February 22nd 2019Komal Jhaveri, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the potential for immunotherapy in the treatment of patients with triple-negative breast cancer (TNBC) based on results from the IMpassion130 trial.
Read More